This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Ecole Polytechnique Federale De Lausanne. Active years: 2011-2012.
Company Filing History:
Years Active: 2011-2012
Title: Innovations in Immunotherapy by Inventor Sai T Reddy
Introduction
Sai T Reddy is a prominent inventor based in Lausanne, Switzerland. He has made significant contributions to the field of immunotherapy, particularly through his innovative work on nanoparticles. With a total of 2 patents, Reddy is recognized for his advancements in targeted drug delivery systems.
Latest Patents
Reddy's latest patents focus on the development of nanoparticles that activate complement in the absence of biological molecules. These nanoparticles are designed to specifically target antigen-presenting cells in lymph nodes, eliminating the need for biological molecules for targeting. This innovative approach allows for the effective delivery of immunotherapeutics, enhancing the potential for successful treatments. The patents also detail various surface chemistries and chemical formulations for these nanoparticles, showcasing Reddy's commitment to advancing medical technology.
Career Highlights
Sai T Reddy is affiliated with the École Polytechnique Fédérale de Lausanne, where he conducts his research and development. His work has garnered attention in the scientific community, contributing to the understanding and application of nanoparticles in immunotherapy.
Collaborations
Reddy collaborates with esteemed colleagues such as Jeffrey Alan Hubbell and André Van Der Vlies. These partnerships enhance the scope and impact of his research, fostering innovation in the field.
Conclusion
Sai T Reddy's contributions to immunotherapy through his innovative nanoparticle technology represent a significant advancement in medical science. His work not only highlights the potential of targeted therapies but also paves the way for future research and development in this critical area.